China, Nov. 2 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'The use of [18F]AlF-NOTA-LM3 PET-CT for response prediction of treating type 2 neurofibromatosis-associated meningiomas with octreotide'. The following are the other relevant details related to the trial:
Registration Number: ChiCTR2600135599
Registration Time: 2026/10/30
Type: Interventional study
Primary Sponsor: Beijing Tiantan Hospital, Capital Medical University
To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=349895
Published by HT Digital Content Services with permission from Health Daily Digest....